INS Ortho, Inc. has successfully patented a new medical innovation, officially registered under Patent Number 12697117, titled “Self-cinching suture construct apparatus.” The newly patented device offers a knotless, self-cinching suture mechanism specifically engineered to repair injured soft tissues, such as a damaged meniscus in the knee.
The design utilizes a continuous loop and a self-cinching suture member. During surgical application, the components are passed through a passage hole in the damaged tissue. The self-cinching member is then threaded through the continuous loop to create a hitch. As tension is applied, a specialized sleeve tightens around the strand in a manner comparable to a finger trap, securing the construct and preventing accidental release of the surgical tension over time.
Innovation and Mechanical Advantages
The fundamental innovation of the Self-cinching suture construct apparatus is its departure from traditional surgical knots, which are often prone to slipping and subsequent loss of tension. By substituting conventional knot tying with a self-cinching mechanism, surgeons can maintain precise and consistent tension on the repaired tissue. The application of a friction locking sleeve means that as stress is applied to the joint during the patient recovery process, the grip on the suture strand dynamically tightens. This structural design drastically reduces the risk of tissue displacement and mitigates the need for corrective surgeries to reapply tension.
Rhode Island Patent of the Month for September 2026
Due to these advancements in orthopedic surgery, INS Ortho, Inc. was awarded the Rhode Island Patent of the Month for September 2026 by Swanson Reed. The invention was recognized for its practical approach to solving common complications associated with transosseous tunnel repairs. Swanson Reed granted this award to highlight the device’s contribution to improving both surgical efficiency and patient recovery times, cementing the apparatus as a notable engineering achievement within the regional medical technology sector.
R&D Tax Credit Eligibility in the United States
The practical applications of this patent create a strong basis for Research and Development (R&D) tax credit eligibility in the USA. Developing a self-cinching medical construct requires comprehensive testing to eliminate technical uncertainties regarding material tensile strength, biomechanical tissue interaction, and long term mechanical reliability. Companies that invest capital into iterative prototyping and biomechanical testing for similar medical devices are engaging in qualified research activities. The systematic trial and error process required to finalize the tension locking mechanism directly aligns with the four part test established by the IRS, allowing such engineering and clinical validation expenses to qualify for federal and state R&D tax credits.
